Please login to the form below

Not currently logged in
Email:
Password:

Stevenage Bioscience Catalyst

This page shows the latest Stevenage Bioscience Catalyst news and features for those working in and with pharma, biotech and healthcare.

Sanofi opens UK bioscience partnering office

Sanofi opens UK bioscience partnering office

Sanofi opens UK bioscience partnering office. Locates new unit at the Stevenage Bioscience Catalyst. ... The French pharma giant is locating the unit at the Stevenage Bioscience Catalyst (pictured above), one of the main bioclusters in the UK located

Latest news

  • Pharma trio join with top universities for new drug search Pharma trio join with top universities for new drug search

    Apollo will be located on the campus of the Stevenage Biosciences Catalyst (pictured above), a bioscience hub that is focused on encouraging open innovation, and will be led by Dr Ian

  • MRC Technology and Peptinnovate join on bone disease MRC Technology and Peptinnovate join on bone disease

    The collaboration is a result of interaction by Stevenage Bioscience Catalyst, where Peptinnovate is based and MRC Technology is relocating next year. ... Martino Picardo, CEO at Stevenage Bioscience Catalyst, added: “ This partnership is just the kind

  • J&J extends partnering network in UK J&J extends partnering network in UK

    The new offices are situated in in Cambridge, Oxford, Manchester, Edinburgh and Cardiff and are a continuation of an open innovation approach J&J first piloted with the Stevenage Bioscience Catalyst

  • J&J extends open innovation with Stevenage office J&J extends open innovation with Stevenage office

    J&J extends open innovation with Stevenage office. Site at Stevenage Bioscience Catalyst expands London Innovation Centre operations. ... Johnson &Johnson (J&J) today upped its efforts in open innovation by opening a partnering office at the Stevenage

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • Opening up innovation Opening up innovation

    With the external immunology board in place, the next step for the Network is GSK's Immunology Catalyst. ... This sees six immunology experts - typically senior academics identified with the help of the board - invited from academia to take a sabbatical

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics